A shifting balance is emerging in the on-chain perpetuals market as trading activity metrics show stiff competition among a small group of fast-growing platformsA shifting balance is emerging in the on-chain perpetuals market as trading activity metrics show stiff competition among a small group of fast-growing platforms

Lighter flips Hyperliquid in 30-day perps volume as competition heats up

A shifting balance is emerging in the on-chain perpetuals market as trading activity metrics show stiff competition among a small group of fast-growing platforms.

Summary
  • Lighter recorded ~$198B in 30-day perpetuals volume, surpassing Hyperliquid’s ~$166B, according to DeFiLlama
  • The LIT token launch and 25% community airdrop helped drive activity and rapid TVL growth to $1.43B
  • Hyperliquid still leads in open interest, spot volume, and revenue, keeping the rivalry unresolved

Lighter has taken the lead over Hyperliquid in 30-day perpetuals trading volume, reshaping the competitive landscape for on-chain derivatives. 

DeFiLlama data shows Lighter processed close to $198 billion in perpetuals trades over the past month, compared with roughly $166 billion on Hyperliquid (HYPE). Aster (ASTER) also moved ahead of Hyperliquid during the same period, posting $174 billion in perps volume. 

Together, the three platforms recorded $972 billion in on-chain perpetuals volume, reflecting how quickly the market has grown heading into 2026.

A volume flip driven by incentives and speed

Throughout 2025, Lighter regularly outpaced Hyperliquid over shorter windows, flipping the lead in 24-hour trading volume several times across September, October, November, and December. The platform’s current 30-day lead indicates that its momentum is no longer confined to short bursts.

The launch of Lighter’s LIT token, which included a 25% community airdrop, has been a major catalyst. As users positioned themselves around point-based rewards and future allocations, trading activity increased sharply. Polymarket markets connected to LIT attracted more than $74 million in volume as speculation quickly followed.

Lighter has drawn high-frequency traders and liquidity seekers by eliminating taker fees for the majority of users, increasing its total value locked from less than $200 million in August to $1.43 billion at the time of publication. Annualized protocol fees are estimated at $105 million, modest compared to competitors but steadily rising.

Hyperliquid still holds key structural advantages

Despite losing the 30-day volume lead, Hyperliquid remains dominant in several areas. It continues to lead in open interest, with $7.3 billion compared to Lighter’s $1.4 billion, and retains a clear edge in spot trading, handling $4.8 billion in volume over the same period versus Lighter’s $3.59 billion.

Revenue generation is also firmly in Hyperliquid’s favor. Annualized fees are estimated at roughly $820 million, far exceeding Lighter’s current figures. 

Analysts point to Lighter’s Ethereum-native composability, expansion into spot markets, and plans around RWAs as long-term strengths. Still, risks remain in what many describe as a winner-take-most market.

Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact [email protected] for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.

You May Also Like

Trump Media & Crypto.com Partner For Shareholder Token Airdrop

Trump Media & Crypto.com Partner For Shareholder Token Airdrop

Trump Media & Technology Group (NASDAQ:DJT) has announced plans to distribute a new digital token to its shareholders, leveraging Crypto.com‘s infraread more
Share
Coinstats2026/01/01 00:23
Tria’s $20m beta surge: How a self-custodial neobank is redefining onchain finance

Tria’s $20m beta surge: How a self-custodial neobank is redefining onchain finance

CEO Vijit Katta shares with crypto.news how Tria is reshaping digital asset banking and paving the way for a frictionless, user-controlled financial future.
Share
Crypto.news2026/01/01 01:00
The FDA Is Trying To Make Corporate Free Speech Situational

The FDA Is Trying To Make Corporate Free Speech Situational

The post The FDA Is Trying To Make Corporate Free Speech Situational appeared on BitcoinEthereumNews.com. BENSENVILLE, ILLINOIS – SEPTEMBER 10: Flanked by U.S. Attorney General Pam Bondi (rear), and FDA Commissioner Marty Makary (R), Secretary of Health and Human Services Robert F. Kennedy Jr. speaks to the press outside Midwest Distribution after it was raided by federal agents on September 10, 2025 in Bensenville, Illinois. According to the company, various e-liquids were seized in the raid. (Photo by Scott Olson/Getty Images) Getty Images While running for President in 2008, Barack Obama famously chanted “Yes we can.” Love or hate his political views, Obama’s politics were quite effective. He was asking voters to think big, to envision a much better future. Advertisers no doubt approved. That’s because ads routinely evoke things not as they are, but as they could be. Gyms and exercise equipment companies don’t promote their locations and equipment with flabby, lumbering people, rather their ads show fit, upright, energetic individuals. A look ahead. Restaurants do the same with ads showing happy people enjoying impressively put together plates of food. Conversely, ads meant to convince smokers to quit have not infrequently shown the worst of the worst future downsides of the habit. The nature of advertising comes to mind as FDA commissioner Marty Makary puzzlingly brags that “The Trump Administration Is Taking On Big Pharma” in the New York Times. Makary laments pharmaceutical ads that “are filled with dancing patients, glowing smiles and catch jingles that drown out the fine print.” Not explained is whether Makary would be happier if drug companies placed ads with immobile patients, frowns, and funereal music. Seriously, what does he expect? Does he want drug companies to commit billions to drug development to accompany their achievements with imagery defined by misery? Has Makary stopped to contemplate the myriad shareholders lawsuits drugmakers would face if, upon risking staggering sums meant…
Share
BitcoinEthereumNews2025/09/18 06:29